Medicosnext
Early on October 2, 2020, U.S. President Donald Trump, 74, revealed that he had tested positive for the novel corona virus. A day earlier, he had tested positive on a rapid test used for screening White House staff , which was later confirmed by a more accurate lab test. He was hospitalized at Walter Reed National Military Medical Center in Maryland from October 2 to October 5, and during his short stay, he received medicines that had shown some effi cacy against COVID-19 in clinical trials.
These included an experimental dual antibody therapy developed by Regeneron Pharmaceuticals Inc; a five-day course of Gilead Sciences Inc’s antiviral, remdesivir; and the steroid, dexamethasone. The president has since been especially appreciative of Regeneron, touting the treatment as a ‘miracle cure’ and promising to make it freely available to all Americans in need. He received the antibody cocktail treatment via a compassionate use request (as clinical trials had not yet been completed and the drug had not yet been approved by the US FDA).
On October 5, his blood samples showed that the he had protective antibodies. On October 8, the president said he is no longer contagious.
Ref: Reuters, October 9, 2020, https://urlzs.com/vwRRh
